Garry Morefield
About
Garry Morefield is from Swiftwater, Pennsylvania, United States. Garry works in the following industries: "Pharmaceutical Manufacturing". Garry is currently Adjunct Faculty at Lehigh University. Garry also works as President at VaxForm, a job Garry has held since Sep 2010. In Garry's previous role as a Deputy Director at Sanofi Pasteur, Garry worked in until Sep 2010. Prior to joining Sanofi Pasteur, Garry was a Post-Doctoral Fellow at National Academy of Sciences and held the position of Post-Doctoral Fellow. Prior to that, Garry was a Post-Doctoral Research Assistant at Purdue University from Aug 2003 to Jun 2004.
Go to finalscout.com and type Garry Morefield's name into the search box for a free email address. FinalScout is a professional database with more than 500 million business professionals and 200 million company executives.
Garry Morefield's current jobs
VaxForm performs consulting/contract services for the development of vaccine formulations. Please visit our website at www.vaxform.com
Garry Morefield's past jobs
Formulation & Stability
Performed research at the United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD. Research Projects Included: •Design and in vitro analysis of next generation staphylococcal enterotoxin B vaccine formulations incorporating Toll-like receptor agonists and aluminum salts as adjuvants. •Pre-clinical testing of optimized vaccine formulations with novel intradermal and transdermal delivery devices in a mouse model of SEB induced toxic shock. •Biocompatibility evaluation of a quadravalent vaccine array comprising recombinant Botulinum Neurotoxin Type A vaccine, recombinant Protective Antigen vaccine (anthrax), recombinant F1-V fusion protein vaccine (plague), and recombinant staphylococcal enterotoxin B vaccine in Rhesus macaques.
Department of Veterinary Pathobiology, Purdue University, West Lafayette, IN Research Project: •Optimization of vaccine immunogenicity by development of methods to control the elution of antigen from aluminum-containing adjuvants following vaccine administration.